Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 9:10:267.
doi: 10.1186/1472-6963-10-267.

Promising outcomes of a national programme for the prevention of Mother-to-Child HIV transmission in Addis Ababa: a retrospective study

Affiliations

Promising outcomes of a national programme for the prevention of Mother-to-Child HIV transmission in Addis Ababa: a retrospective study

Alemnesh H Mirkuzie et al. BMC Health Serv Res. .

Abstract

Background: Prevention of Mother-to-Child HIV Transmission (PMTCT) is still the most effective intervention in combating new HIV infections. In 2008, revised national PMTCT guidelines that incorporated new policies on HIV counselling and testing, antiretroviral prophylaxis regimen and infant HIV diagnosis came into effect in Ethiopia. In the present study we have examined trends in PMTCT service utilization and assessed the rate of MTCT in relation to policy changes in the national PMTCT programme.

Methods: Reports from February 2004 to August 2009 were reviewed in 10 sub-cities in Addis Ababa, Ethiopia. The data was collected from May to October 2009.

Results: The proportion of women who received HIV counselling and testing among new antenatal care attendees increased from 50.7% (95% CI 50.2-51.2) in 2007 to 84.5% (95% CI 84.1-84.9) in 2009 following the shift to routine opt-out testing. Nevertheless, in 2009 only 53.7% of the positive women and 40.7% of their infants received antiretroviral prophylaxis. The HIV prevalence among antenatal attendees decreased significantly from 10.5% in 2004 to 4.6% in 2009 in parallel to the increased number of women being tested. The HIV positive women were over 18 times (RR 18.5, p < 0.0001) more likely to be referred for treatment, care and support in 2009 than in 2004. The proportion of partners tested for HIV decreased by 14% in 2009 compared to 2004, although the absolute number was increasing year by year. Only 10.6% (95% CI 9.9-11.2) of the HIV positive women completed their follow up to infant HIV testing. The cumulative probability of HIV infection among babies on single dose nevirapine regimen who were tested at >=18 months was 15.0% (95% CI 9.8-22.1) in 2007, whereas it was 8.2% (95% CI 5.55-11.97) among babies on Zidovudine regimen who were tested at >=45 days in 2009.

Conclusion: The paper demonstrates trends in PMTCT service utilization in relation to changing policy. There is marked improvement in HIV counselling and testing service utilization, especially after the policy shift to routine opt-out testing. However, despite policy changes, the ARV prophylaxis uptake, the loss to follow up and the partner testing have remained unchanged across the years. This should be a matter of immediate concern and a topic for further research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportion of women who received pre-test counselling, testing and post-test counselling among new ANC attendees. --- In 2004 to 2007 when the HIV testing was offered in an opt-in approach. ___In 2008 and 2009 when the HIV testing was offered routinely in an opt-out approach.
Figure 2
Figure 2
Trends in HIV prevalence among antenatal care attendees tested in PMTCT settings from 2004 to 2009 in Addis Ababa.
Figure 3
Figure 3
Percentage of women and babies who received ARV prophylaxis from 2004 to 2009 in Addis Ababa.
Figure 4
Figure 4
HIV infection among exposed babies tested for HIV from 2006 to 2009 in Addis Ababa.
Figure 5
Figure 5
Trends in partner testing in the PMTCT settings from 2004 to 2009 in Addis Ababa.

References

    1. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach.- 2006 version. WHO: Geneva; 2006. - PubMed
    1. Letvin NL. Virology. Moving forward in HIV vaccine development. Science (New York, N.Y.) 2009;326(5957):1196–8. - PubMed
    1. Potts M. et al.Public health. Reassessing HIV prevention. Science (New York, N.Y.) 2008;320(5877):749–50. - PMC - PubMed
    1. HAPCO/GAMET. HIV/AIDS in Ethiopia - An Epidemiological Synthesis. Washington DC. 2008.
    1. UNAIDS/WHO. UNAIDS/WHO Policy statement on HIV testing. WHO: Geneva; 2004.

Publication types

MeSH terms

Substances